Pear Therapeutics, Inc. Warrant
PEARW
PEARW was delisted on the 18th of April, 2023.
44 hedge funds and large institutions have $4.47M invested in Pear Therapeutics, Inc. Warrant in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 2 increasing their positions, 11 reducing their positions, and 21 closing their positions.
14% less funds holding
Funds holding: 51 → 44 (-7)
33% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 21
44% less capital invested
Capital invested by funds: $7.97M → $4.47M (-$3.5M)
82% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCAM
Owl Creek Asset Management
New York
|
+$420K |
| 2 |
BlackRock
New York
|
+$248K |
| 3 |
AR
Advisory Research
Chicago,
Illinois
|
+$217K |
| 4 |
MA
MYDA Advisors
Woodmere,
New York
|
+$60.9K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$42.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$1.82M |
| 2 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$317K |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$262K |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$233K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$200K |
PEARW Hedge Fund Activity: Q4 2021 in Review
44 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Pear Therapeutics, Inc. Warrant (PEARW) for Q4 2021, worth a combined $4.47M — down 44% from $7.97M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of PEARW and 14 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 2 added.
The largest buyer was Owl Creek Asset Management, opening a new position worth an estimated $420K. The largest seller was Radcliffe Capital Management, exiting entirely with an estimated $1.82M sold.
- 44 institutional investors held Pear Therapeutics, Inc. Warrant (PEARW) as of Q4 2021, down from 51 in Q3 2021.
- Funds reported $4.47M of Pear Therapeutics, Inc. Warrant stock for Q4 2021, down 44% quarter-over-quarter.
- 14 funds opened new Pear Therapeutics, Inc. Warrant positions in Q4 2021 and 21 closed out, a net change of -7 holders.
- The largest Pear Therapeutics, Inc. Warrant buyer in Q4 2021 was Owl Creek Asset Management, an estimated $420K added.
- The largest Pear Therapeutics, Inc. Warrant seller in Q4 2021 was Radcliffe Capital Management, an estimated $1.82M sold.
Based on aggregated 13F filings for Q4 2021.